Travere Therapeutics, Inc.TVTX
| Feb 29, 2012 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Cash and cash equivalents | - | 11,388 | 6 | - | 38 | 41 | 99 | 103 | 62 | 85 | 166 | 62 | 58 |
---|
Debt Securities, Available-for-Sale | - | - | - | - | - | - | - | 369 | 336 | 277 | 387 | 389 | 509 |
---|
Accounts receivable, net | - | - | - | - | 12 | 19 | 14 | 14 | 18 | 16 | 16 | 17 | 21 |
---|
Inventory, net | - | - | - | - | 3 | 3 | 5 | 6 | 6 | 8 | 7 | 7 | 9 |
---|
Prepaid expenses and other current assets | - | - | 1 | - | 2 | 5 | 3 | 2 | 5 | 8 | 6 | 13 | 19 |
---|
Total current assets | - | 33,218 | 8 | - | 302 | 332 | 326 | 496 | 429 | 410 | 583 | 486 | 617 |
---|
Total current assets | - | 33,218 | 8 | - | 302 | 332 | 326 | 496 | 429 | 410 | 583 | 486 | 617 |
---|
Property and equipment, net | - | 23,790 | 127,427 | - | 0 | 3 | 3 | 3 | 3 | 9 | 11 | 9 | 7 |
---|
Inventory, Noncurrent | - | - | - | - | - | - | - | - | - | - | - | - | 31 |
---|
Operating lease right of use assets | - | - | - | - | - | - | - | - | - | - | 23 | 21 | 18 |
---|
Property and equipment, net | - | 23,790 | 127,427 | - | 0 | 3 | 3 | 3 | 3 | 9 | 11 | 9 | 7 |
---|
Intangible assets, net | - | - | - | - | - | 182 | 185 | 187 | 157 | 153 | 148 | 145 | 104 |
---|
Operating lease right of use assets | - | - | - | - | - | - | - | - | - | - | 23 | 21 | 18 |
---|
Other assets | - | - | - | - | 2 | 7 | 6 | 8 | 15 | 33 | 11 | 11 | 11 |
---|
Intangible assets, net | - | - | - | - | - | 182 | 185 | 187 | 157 | 153 | 148 | 145 | 104 |
---|
Total assets | - | 2 | 20 | - | 512 | 525 | 520 | 709 | 605 | 607 | 777 | 673 | 789 |
---|
Other assets | - | - | - | - | 2 | 7 | 6 | 8 | 15 | 33 | 11 | 11 | 11 |
---|
Total assets | - | 2 | 20 | - | 512 | 525 | 520 | 709 | 605 | 607 | 777 | 673 | 789 |
---|
Accounts payable | - | 1 | 4 | - | 8 | 8 | 19 | 7 | 27 | 12 | 15 | 17 | 42 |
---|
Accrued expenses | 66,989 | 2 | 3 | - | 24 | 33 | 36 | 50 | 52 | 57 | 75 | 96 | 119 |
---|
Deferred revenue, current portion | - | - | - | - | - | - | - | - | - | - | 16 | 12 | 7 |
---|
Business Combination, Contingent Consideration, Liability, Current | - | - | - | - | - | - | - | - | - | - | 7 | 7 | - |
---|
Operating Lease, Liability, Current | - | - | - | - | - | - | - | - | - | - | 4 | 4 | 5 |
---|
Other current liabilities | - | - | - | - | 1 | 2 | 4 | 4 | 9 | 6 | 6 | 6 | 5 |
---|
Total current liabilities | - | 6 | 35 | - | 86 | 83 | 86 | 105 | 95 | 93 | 124 | 142 | 178 |
---|
Accounts payable | - | 1 | 4 | - | 8 | 8 | 19 | 7 | 27 | 12 | 15 | 17 | 42 |
---|
Accrued expenses | 66,989 | 2 | 3 | - | 24 | 33 | 36 | 50 | 52 | 57 | 75 | 96 | 119 |
---|
Deferred revenue, current portion | - | - | - | - | - | - | - | - | - | - | 16 | 12 | 7 |
---|
Operating Lease, Liability, Current | - | - | - | - | - | - | - | - | - | - | 4 | 4 | 5 |
---|
Other current liabilities | - | - | - | - | 1 | 2 | 4 | 4 | 9 | 6 | 6 | 6 | 5 |
---|
Total current liabilities | - | 6 | 35 | - | 86 | 83 | 86 | 105 | 95 | 93 | 124 | 142 | 178 |
---|
Convertible debt | - | - | - | - | 44 | 44 | 45 | 195 | 205 | 215 | 227 | 376 | 377 |
---|
Deferred revenue, less current portion | - | - | - | - | - | - | - | - | - | - | 20 | 11 | 2 |
---|
Business Combination, Contingent Consideration, Liability, Noncurrent | - | - | - | - | - | - | - | - | - | - | 60 | 64 | - |
---|
Operating Lease, Liability, Noncurrent | - | - | - | - | - | - | - | - | - | - | 31 | 28 | 23 |
---|
Operating Lease, Liability, Noncurrent | - | - | - | - | - | - | - | - | - | - | 31 | 28 | 23 |
---|
Other non-current liabilities | - | - | - | - | 3 | 4 | 2 | 4 | 21 | 41 | 12 | 9 | 8 |
---|
Other non-current liabilities | - | - | - | - | 3 | 4 | 2 | 4 | 21 | 41 | 12 | 9 | 8 |
---|
Total liabilities | - | 6 | 39 | - | 212 | 218 | 227 | 391 | 384 | 396 | 475 | 630 | 588 |
---|
Preferred Stock, Value, Issued | - | - | - | - | - | - | - | - | - | - | - | - | - |
---|
Common Stock, Value, Issued | - | 895 | 1,855 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Additional paid-in capital | 72,989 | 30 | 50 | - | 366 | 421 | 472 | 590 | 637 | 798 | 1,069 | 1,060 | 1,328 |
---|
Accumulated deficit | -136,081 | - | - | - | -65 | -113 | -178 | -270 | -416 | -586 | -766 | -1,014 | -1,126 |
---|
Accumulated other comprehensive loss | - | - | -109,987 | - | -1 | -0 | -1 | -2 | 1 | -1 | -1 | -3 | -1 |
---|
Total stockholders' equity | -63,080 | -3,407,815 | -18,311,898 | - | 300 | 308 | 293 | 318 | 221 | 211 | 302 | 43 | 201 |
---|
Total liabilities and stockholders' equity | 3 | 2 | 20 | - | 512 | 525 | 520 | 709 | 605 | 607 | 777 | 673 | 789 |
---|